HomeBY BUSINESS CHALLENGESPricing Research

Pricing Research

  • Market Assessment for Contrast Agents in ASEAN

    • May 24, 2020
    • Posted by: Team EMeRG
    • Category: GTM Strategy, ICU equipment, Maternal & Infant Care, Patient Monitoring, Pricing Research
    No Comments
    Our Client: A global medical devices firm and leading pharma diagnostics company Challenge Statement: Our client was looking to understand the market dynamics and competitive landscape to push their existing contrast agents while launching new products across specific customer segments within ASEAN EMeRG Approach:  Using our proprietary HospeTrack database, in-depth segmentation of individual hospitals was conducted across
    read more

  • Mapping of Oncology Infrastructure and Need-gap analysis across ASEAN and APAC

    • January 31, 2020
    • Posted by: Team EMeRG
    • Category: APAC / ASEAN, BY MEDICAL TECHNOLOGIES, GTM Strategy, ICU equipment, Market Entry Assessment, Maternal & Infant Care, Operating Room devices, Patient Monitoring, Pricing Research
    No Comments
    Our Client: A global medical technologies manufacturer dealing with medical devices, medical consumables and drug delivery systems Challenge Statement: For strategic planning regarding pricing, market access and overall marketing strategy, the client wanted to understand the future outlook of reimbursement of medical consumables in India EMeRG Approach:  Desk Research - An exhaustive desk research was conducted across medical literature and commercial open sources to map the impact of diabetes on Indian population. Desk research was also conducted  to understand the current market dynamics of medical consumables and pathology labs in India In Depth Interviews were conducted with diabetologists and other specialists, Medical Directors of hospitals; pathology lab owners; BU Heads and product managers at Health insurance  companies; pharmacists and patients Research Outcome: Reimbursement as a terminology was loosely understood in India. The possibility of medical consumables and diabetes delivery products being included
    read more

  • Market size estimation for Radiography equipment in India

    • March 22, 2018
    • Posted by: Team EMeRG
    • Category: APAC / ASEAN, BY MEDICAL TECHNOLOGIES, Competitive Intelligence, Diagnostic Imaging, GTM Strategy, Pricing Research, Value Prop Assessment
    No Comments
    Overview: Radiography Equipment Market in India Valued at $45Mn in 2016, the Indian Radiography market is being driven by strong preference for Digital Radiography (DR)  by large corporate and government hospitals due to increasing patient footfall. The predecessor of DR, the Analog X-ray segment is likely to exhibit muted growth due to the increasing preference
    read more

  • Pricing and Value Proposition Assessment for Ultrasound Machines In India

    • November 15, 2017
    • Posted by: Team EMeRG
    • Category: APAC / ASEAN, BY MEDICAL TECHNOLOGIES, Diagnostic Imaging, Market Entry Assessment, Maternal & Infant Care, NPI Research, Pricing Research, Value Prop Assessment
    No Comments
    “45% of the non-owners of ultrasound interviewed were Obs/Gyn specialists, practicing for >16 years. Clearly, adoption of ultrasound in India would take more than just lowering price points…” Overview: Ultrasound Market in India Valued at $170Mn in 2016, the market for diagnostic ultrasound in India is characterized by immense fragmentation. While on the one hand,
    read more

  • Evaluation of business models and marketing strategies for a Tele-Health solution

    • February 13, 2017
    • Posted by: Team EMeRG
    • Category: APAC / ASEAN, BY MEDICAL TECHNOLOGIES, Competitive Intelligence, GTM Strategy, Healthcare IT, Market Entry Assessment, NPI Research, Pricing Research, Value Prop Assessment
    No Comments
    Overview: Market for Tele-Health solutions in India Limited healthcare access across rural and semi-urban India is causing significant loss w.r.t. disability adjusting life years amounting to economic loses worth $200 trillion. Despite 70% of the population being spread across rural India, urban parts account for 60% of the workforce. Tele-health initiatives, though not highly commercially viable
    read more

  • New Product Introduction: Non-invasive solution for measuring HbA1c

    • October 10, 2016
    • Posted by: Team EMeRG
    • Category: APAC / ASEAN, BY MEDICAL TECHNOLOGIES, Competitive Intelligence, Diabetes Management, Ethnographic Research, Market Entry Assessment, NPI Research, Pricing Research, SUBCONTINENT
    No Comments
    Overview: Market for HbA1c Tests  The global market for Self monitoring blood glucose (SMBG) devices was valued at $11Bn in 2015 and is characterized by intense competition and low entry barriers for low-cost manufacturers. In India, the market for SMBG devices and strips was valued at about $98Mn in 2015.While the annual median expenditure on
    read more

  • New Product Introduction: Low-cost visualization device for body orifices

    • September 10, 2016
    • Posted by: Team EMeRG
    • Category: APAC / ASEAN, BY MEDICAL TECHNOLOGIES, Competitive Intelligence, Ethnographic Research, Market Entry Assessment, NPI Research, Operating Room devices, Pricing Research
    No Comments
    Overview: Market for Endoscopic Products in India The global market for endoscopic products was valued at over $29Bn in 2015, growing at over 6% annually. India represents about 0.35% of the global markets, being valued at $115Mn. Rigid endoscopes continue to dominate sales in India, accounting for over 62% of the market revenues. Future innovations
    read more

  • Feasibility assessment and pricing strategy for the launch of diagnostic lab chains in India

    • December 13, 2015
    • Posted by: Team EMeRG
    • Category: APAC / ASEAN, BY MEDICAL TECHNOLOGIES, Diagnostic Imaging, GTM Strategy, Market Entry Assessment, NPI Research, Pricing Research, Value Prop Assessment
    No Comments
    Overview: Market for Diagnostic labs in India In India, 70% of the treatment decisions are made based on lab results. Valued at over $7Bn, the diagnostics industry in India is largely unregulated and unorganized.  While accreditation is optional, there are <800 medical labs that have been accredited by NABL. This represents roughly 1% of all
    read more

  • Business Case Creation for a US-Based Novel Blood Glucose Monitoring Company

    • November 18, 2015
    • Posted by: Team EMeRG
    • Category: APAC / ASEAN, BY BUSINESS CHALLENGES, BY MEDICAL TECHNOLOGIES, Diabetes Management, Market Entry Assessment, NPI Research, Pricing Research
    No Comments
    “CGM with infusion pump is very expensive for patients to buy. In India, hardly a few patients have CGM -  let alone infusion pumps. Now with newer technology I hope cost comes down and more patients have access to continuous monitoring. In Metropolitan cities around 5 % of the diabetic population would buy SMBG monitors.
    read more

  • New Product Introduction – Integrated Vital Signs Monitoring Solution

    • November 9, 2015
    • Posted by: Team EMeRG
    • Category: APAC / ASEAN, BY MEDICAL TECHNOLOGIES, Competitive Intelligence, Ethnographic Research, Market Entry Assessment, NPI Research, Patient Monitoring, Pricing Research, Value Prop Assessment
    No Comments
    Overview: Vital Signs Monitoring Market in India Valued at over $3.5Bn, the global vital signs market is demonstrating significant growth in emerging markets especially across secondary care. With the need for early detection, and quick diagnosis prior to referrals, the need for vital signs monitoring is on the rise in primary care settings. The market
    read more
  • 1
  • 2